Kaycide T 281.25 Injection
Marketer
Stenkem Molecules Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Kaycide T 281.25 Injection
Kaycide T 281.25 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus controlling infection spread. Administration must be solely under a physician's guidance; strictly adhere to prescribed dosage schedules. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostic evaluations to monitor treatment response.
Primary Ingredients of Kaycide T 281.25 Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text can be provided.
Uses of Kaycide T 281.25 Injection
Infections caused by bacteria
Major Benefits of Kaycide T 281.25 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Kaycide T 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kaycide T 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Kaycide T 281.25 Injection works:
Kaycide T 281.25 Injection combines Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of Kaycide T 281.25 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Kaycide T 281.25 is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent harm to the fetus; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Kaycide T 281.25 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Kaycide T 281.25 Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Kaycide T 281.25 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Kaycide T 281.25 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kaycide T 281.25 Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kaycide T 281.25 Injection :
Omitting a scheduled dose of Kaycide T 281.25 Injection warrants immediate physician consultation.
Facts to Know About Kaycide T 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently